Global Biologics and Biosimilars Market Research Report 2022 (Status and Outlook)

1 Research Methodology and Statistical Scope1
1.1 Market Definition and Statistical Scope of Biologics and Biosimilars1
1.2 Key Market Segments1
1.2.1 Biologics and Biosimilars Segment by Type1
1.2.2 Biologics and Biosimilars Segment by Application2
1.3 Methodology & Sources of Information3
1.3.1 Research Methodology3
1.3.2 Research Process4
1.3.3 Market Breakdown and Data Triangulation5
1.3.4 Base Year5
1.3.5 Report Assumptions & Caveats6

2 Biologics and Biosimilars Market Overview8
2.1 Global Market Overview8
2.1.1 Global Biologics and Biosimilars Market Size (M USD) Estimates and Forecasts (2017-2028)8
2.1.2 Global Biologics and Biosimilars Sales Estimates and Forecasts (2017-2028)9
2.2 Market Segment Executive Summary9
2.3 Global Market Size by Region11

3 Biologics and Biosimilars Market Competitive Landscape13
3.1 Global Biologics and Biosimilars Sales by Manufacturers (2017-2022)13
3.2 Global Biologics and Biosimilars Revenue Market Share by Manufacturers (2017-2022)15
3.3 Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)16
3.4 Global Biologics and Biosimilars Average Price by Manufacturers (2017-2022)17
3.5 Manufacturers Biologics and Biosimilars Sales Sites, Area Served, Product Type18
3.6 Biologics and Biosimilars Market Competitive Situation and Trends19
3.6.1 Biologics and Biosimilars Market Concentration Rate19
3.6.2 Global 5 and 10 Largest Biologics and Biosimilars Players Market Share by Revenue21
3.6.3 Mergers & Acquisitions, Expansion21

4 Biologics and Biosimilars Industry Chain Analysis22
4.1 Biologics and Biosimilars Industry Chain Analysis22
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials22
4.3 Midstream Market Analysis23
4.4 Downstream Customer Analysis23

5 The Development and Dynamics of Biologics and Biosimilars Market25
5.1 Key Development Trends25
5.2 Driving Factors25
5.3 Market Challenges25
5.4 Market Restraints26
5.5 Industry News26
5.5.1 New Product Developments26
5.5.2 Mergers & Acquisitions26
5.5.3 Expansions26
5.5.4 Collaboration/Supply Contracts26
5.6 Industry Policies26

6 Biologics and Biosimilars Market Segmentation by Type27
6.1 Evaluation Matrix of Segment Market Development Potential (Type)27
6.2 Global Biologics and Biosimilars Sales Market Share by Type (2017-2022)28
6.3 Global Biologics and Biosimilars Market Size Market Share by Type (2017-2022)29
6.4 Global Biologics and Biosimilars Price by Type (2017-2022)30

7 Biologics and Biosimilars Market Segmentation by Application31
7.1 Evaluation Matrix of Segment Market Development Potential (Application)31
7.2 Global Biologics and Biosimilars Market Sales by Application (2017-2022)32
7.3 Global Biologics and Biosimilars Market Size (M USD) by Application (2017-2022)33
7.4 Global Biologics and Biosimilars Sales Growth Rate by Application (2017-2022)34

8 Biologics and Biosimilars Market Segmentation by Region35
8.1 Global Biologics and Biosimilars Sales by Region35
8.1.1 Global Biologics and Biosimilars Sales by Region35
8.1.2 Global Biologics and Biosimilars Sales Market Share by Region35
8.2 North America36
8.2.1 North America Biologics and Biosimilars Sales by Country36
8.2.2 U.S.37
8.2.3 Canada37
8.2.4 Mexico37
8.3 Europe37
8.3.1 Europe Biologics and Biosimilars Sales by Country38
8.3.2 Germany38
8.3.3 France38
8.3.4 U.K.38
8.3.5 Italy39
8.3.6 Russia39
8.4 Asia Pacific39
8.4.1 Asia Pacific Biologics and Biosimilars Sales by Region39
8.4.2 China40
8.4.3 Japan40
8.4.4 South Korea40
8.4.5 India40
8.4.6 Southeast Asia40
8.5 South America40
8.5.1 South America Biologics and Biosimilars Sales by Country41
8.5.2 Brazil41
8.5.3 Argentina41
8.5.4 Columbia41
8.6 Middle East and Africa41
8.6.1 Middle East and Africa Biologics and Biosimilars Sales by Region42
8.6.2 Saudi Arabia42
8.6.3 UAE42
8.6.4 Egypt42
8.6.5 Nigeria43
8.6.6 South Africa43

9 Key Companies Profiled44
9.1 Roche44
9.1.1 Roche Biologics and Biosimilars Basic Information44
9.1.2 Roche Biologics and Biosimilars Product Overview44
9.1.3 Roche Biologics and Biosimilars Product Market Performance44
9.1.4 Roche Business Overview45
9.1.5 Roche Biologics and Biosimilars SWOT Analysis45
9.1.6 Roche Recent Developments45
9.2 Amgen46
9.2.1 Amgen Biologics and Biosimilars Basic Information46
9.2.2 Amgen Biologics and Biosimilars Product Overview46
9.2.3 Amgen Biologics and Biosimilars Product Market Performance46
9.2.4 Amgen Business Overview47
9.2.5 Amgen Biologics and Biosimilars SWOT Analysis47
9.2.6 Amgen Recent Developments47
9.3 AbbVie47
9.3.1 AbbVie Biologics and Biosimilars Basic Information47
9.3.2 AbbVie Biologics and Biosimilars Product Overview48
9.3.3 AbbVie Biologics and Biosimilars Product Market Performance48
9.3.4 AbbVie Business Overview48
9.3.5 AbbVie Biologics and Biosimilars SWOT Analysis49
9.3.6 AbbVie Recent Developments49
9.4 Sanofi-Aventis49
9.4.1 Sanofi-Aventis Biologics and Biosimilars Basic Information49
9.4.2 Sanofi-Aventis Biologics and Biosimilars Product Overview50
9.4.3 Sanofi-Aventis Biologics and Biosimilars Product Market Performance50
9.4.4 Sanofi-Aventis Business Overview50
9.4.5 Sanofi-Aventis Biologics and Biosimilars SWOT Analysis50
9.4.6 Sanofi-Aventis Recent Developments51
9.5 Johnson & Johnson51
9.5.1 Johnson & Johnson Biologics and Biosimilars Basic Information51
9.5.2 Johnson & Johnson Biologics and Biosimilars Product Overview51
9.5.3 Johnson & Johnson Biologics and Biosimilars Product Market Performance52
9.5.4 Johnson & Johnson Business Overview52
9.5.5 Johnson & Johnson Biologics and Biosimilars SWOT Analysis52
9.5.6 Johnson & Johnson Recent Developments52
9.6 Pfizer53
9.6.1 Pfizer Biologics and Biosimilars Basic Information53
9.6.2 Pfizer Biologics and Biosimilars Product Overview53
9.6.3 Pfizer Biologics and Biosimilars Product Market Performance53
9.6.4 Pfizer Business Overview54
9.6.5 Pfizer Recent Developments54
9.7 Novo Nordisk54
9.7.1 Novo Nordisk Biologics and Biosimilars Basic Information54
9.7.2 Novo Nordisk Biologics and Biosimilars Product Overview55
9.7.3 Novo Nordisk Biologics and Biosimilars Product Market Performance55
9.7.4 Novo Nordisk Business Overview55
9.7.5 Novo Nordisk Recent Developments55
9.8 Eli Lilly56
9.8.1 Eli Lilly Biologics and Biosimilars Basic Information56
9.8.2 Eli Lilly Biologics and Biosimilars Product Overview56
9.8.3 Eli Lilly Biologics and Biosimilars Product Market Performance56
9.8.4 Eli Lilly Business Overview57
9.8.5 Eli Lilly Recent Developments57
9.9 Novartis57
9.9.1 Novartis Biologics and Biosimilars Basic Information57
9.9.2 Novartis Biologics and Biosimilars Product Overview58
9.9.3 Novartis Biologics and Biosimilars Product Market Performance58
9.9.4 Novartis Business Overview58
9.9.5 Novartis Recent Developments58
9.10 Merck59
9.10.1 Merck Biologics and Biosimilars Basic Information59
9.10.2 Merck Biologics and Biosimilars Product Overview59
9.10.3 Merck Biologics and Biosimilars Product Market Performance59
9.10.4 Merck Business Overview60
9.10.5 Merck Recent Developments60
9.11 3sbio60
9.11.1 3sbio Biologics and Biosimilars Basic Information60
9.11.2 3sbio Biologics and Biosimilars Product Overview61
9.11.3 3sbio Biologics and Biosimilars Product Market Performance61
9.11.4 3sbio Business Overview61
9.11.5 3sbio Recent Developments61
9.12 Changchun High Tech62
9.12.1 Changchun High Tech Biologics and Biosimilars Basic Information62
9.12.2 Changchun High Tech Biologics and Biosimilars Product Overview62
9.12.3 Changchun High Tech Biologics and Biosimilars Product Market Performance62
9.12.4 Changchun High Tech Business Overview63
9.12.5 Changchun High Tech Recent Developments63
9.13 CP Guojian63
9.13.1 CP Guojian Biologics and Biosimilars Basic Information63
9.13.2 CP Guojian Biologics and Biosimilars Product Overview64
9.13.3 CP Guojian Biologics and Biosimilars Product Market Performance64
9.13.4 CP Guojian Business Overview64
9.13.5 CP Guojian Recent Developments64
9.14 Biotech65
9.14.1 Biotech Biologics and Biosimilars Basic Information65
9.14.2 Biotech Biologics and Biosimilars Product Overview65
9.14.3 Biotech Biologics and Biosimilars Product Market Performance65
9.14.4 Biotech Business Overview66
9.14.5 Biotech Recent Developments66
9.15 Gelgen66
9.15.1 Gelgen Biologics and Biosimilars Basic Information66
9.15.2 Gelgen Biologics and Biosimilars Product Overview67
9.15.3 Gelgen Biologics and Biosimilars Product Market Performance67
9.15.4 Gelgen Business Overview67
9.15.5 Gelgen Recent Developments67
9.16 Innovent68
9.16.1 Innovent Biologics and Biosimilars Basic Information68
9.16.2 Innovent Biologics and Biosimilars Product Overview68
9.16.3 Innovent Biologics and Biosimilars Product Market Performance68
9.16.4 Innovent Business Overview69
9.16.5 Innovent Recent Developments69
9.17 Dong Bao69
9.17.1 Dong Bao Biologics and Biosimilars Basic Information69
9.17.2 Dong Bao Biologics and Biosimilars Product Overview70
9.17.3 Dong Bao Biologics and Biosimilars Product Market Performance70
9.17.4 Dong Bao Business Overview70
9.17.5 Dong Bao Recent Developments70
9.18 Ganlee71
9.18.1 Ganlee Biologics and Biosimilars Basic Information71
9.18.2 Ganlee Biologics and Biosimilars Product Overview71
9.18.3 Ganlee Biologics and Biosimilars Product Market Performance71
9.18.4 Ganlee Business Overview72
9.18.5 Ganlee Recent Developments72
9.19 United Laboratories72
9.19.1 United Laboratories Biologics and Biosimilars Basic Information72
9.19.2 United Laboratories Biologics and Biosimilars Product Overview73
9.19.3 United Laboratories Biologics and Biosimilars Product Market Performance73
9.19.4 United Laboratories Business Overview73
9.19.5 United Laboratories Recent Developments73
10 Biologics and Biosimilars Market Forecast by Region106
10.1 Global Biologics and Biosimilars Market Size Forecast106
10.2 Global Biologics and Biosimilars Market Forecast by Region106
10.2.1 North America Market Size Forecast by Country107
10.2.2 Europe Biologics and Biosimilars Market Size Forecast by Country108
10.2.3 Asia Pacific Biologics and Biosimilars Market Size Forecast by Region108
10.2.4 South America Biologics and Biosimilars Market Size Forecast by Country109
10.2.5 Middle East and Africa Forecasted Consumption of Biologics and Biosimilars by Country109
11 Forecast Market by Type and by Application (2022-2028)111
11.1 Global Biologics and Biosimilars Market Forecast by Type (2022-2028)111
11.1.1 Global Forecasted Sales of Biologics and Biosimilars by Type (2022-2028)111
11.1.2 Global Biologics and Biosimilars Market Size Forecast by Type (2022-2028)111
11.1.3 Global Forecasted Price of Biologics and Biosimilars by Type (2022-2028)112
11.2 Global Biologics and Biosimilars Market Forecast by Application (2022-2028)112
11.2.1 Global Biologics and Biosimilars Sales (K Units) Forecast by Application112
11.2.2 Global Biologics and Biosimilars Market Size (M USD) Forecast by Application (2022-2028)113
12 Conclusion and Key Findings114